Literature DB >> 10827211

Glutamine appearance rate in plasma is not increased after gastrointestinal surgery in humans.

B A van Acker1, K W Hulsewé, A J Wagenmakers, P B Soeters, M F von Meyenfeldt.   

Abstract

The metabolic response to surgical stress is characterized by muscle protein breakdown and mobilization of amino acids and has been postulated to furnish glutamine and other amino acids to the immune system, gut and liver. The present study was undertaken to investigate whether the whole body appearance rate (R(a))(3) of glutamine in plasma is increased after major elective surgery. Fourteen patients (8 males, 6 females) were measured prior to laparotomy and on the second postoperative day. Patients received a primed continuous 6-h infusion of L-[5-(15) N]glutamine and L-[1-(13)C]leucine, and arterial blood samples and muscle biopsies were taken for concentration and enrichment measurements. As expected, the metabolic response to surgery was characterized by a rise in whole body protein breakdown (n = 14, P < 0.001) and a decreased concentration of glutamine in plasma (n = 14, P < 0.001) and muscle (n = 8, P < 0.01). However, these catabolic changes were not reflected by an increase in the plasma R(a) of glutamine: 246 +/- 8 micromol. kg(-1). h(-1) before surgery vs. 241 +/- 10 micromol. kg(-1). h(-1) on the second postoperative day. We conclude that the whole body R(a) of glutamine in plasma is not increased 2 d after elective gastrointestinal surgery. Further studies are warranted to establish whether the lack of an increase in plasma glutamine R(a) provides a rationale for glutamine supplementation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10827211     DOI: 10.1093/jn/130.6.1566

Source DB:  PubMed          Journal:  J Nutr        ISSN: 0022-3166            Impact factor:   4.798


  9 in total

Review 1.  Pharmacogenomics and end-organ susceptibility to injury in the perioperative period.

Authors:  Debra A Schwinn; Mihai Podgoreanu
Journal:  Best Pract Res Clin Anaesthesiol       Date:  2008-03

2.  Novel events in the molecular regulation of muscle mass in critically ill patients.

Authors:  Despina Constantin; Justine McCullough; Ravi P Mahajan; Paul L Greenhaff
Journal:  J Physiol       Date:  2011-06-13       Impact factor: 5.182

3.  Intestinal and hepatic metabolism of glutamine and citrulline in humans.

Authors:  Marcel C G van de Poll; Gerdien C Ligthart-Melis; Petra G Boelens; Nicolaas E P Deutz; Paul A M van Leeuwen; Cornelis H C Dejong
Journal:  J Physiol       Date:  2007-03-08       Impact factor: 5.182

4.  Glutamine and glutathione at ICU admission in relation to outcome.

Authors:  Paul Castillo Rodas; Olav Rooyackers; Christina Hebert; Åke Norberg; Jan Wernerman
Journal:  Clin Sci (Lond)       Date:  2012-06       Impact factor: 6.124

Review 5.  Glutamine supplementation to critically ill patients?

Authors:  Jan Wernerman
Journal:  Crit Care       Date:  2014-03-18       Impact factor: 9.097

Review 6.  Effect of glutamine dipeptide supplementation on primary outcomes for elective major surgery: systematic review and meta-analysis.

Authors:  Marta Sandini; Luca Nespoli; Massimo Oldani; Davide Paolo Bernasconi; Luca Gianotti
Journal:  Nutrients       Date:  2015-01-09       Impact factor: 5.717

7.  Prevalence of glutamine deficiency in ICU patients: a cross-sectional analytical study.

Authors:  Arista Nienaber; Robin Claire Dolman; Averalda Eldorine van Graan; Renee Blaauw
Journal:  Nutr J       Date:  2016-08-02       Impact factor: 3.271

8.  Endogenous glutamine production in critically ill patients: the effect of exogenous glutamine supplementation.

Authors:  Maiko Mori; Olav Rooyackers; Marie Smedberg; Inga Tjäder; Ake Norberg; Jan Wernerman
Journal:  Crit Care       Date:  2014-04-14       Impact factor: 9.097

9.  Prolonged continuous intravenous infusion of the dipeptide L-alanine- L-glutamine significantly increases plasma glutamine and alanine without elevating brain glutamate in patients with severe traumatic brain injury.

Authors:  Mirjam Nägeli; Mario Fasshauer; Jutta Sommerfeld; Angela Fendel; Giovanna Brandi; John F Stover
Journal:  Crit Care       Date:  2014-07-02       Impact factor: 9.097

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.